Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 253
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00450424 | Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer | ||
| NCT02126319 | Facilitating Participation in a Prostate Cancer Risk Assessment Program | ||
| NCT01169532 | Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma | ||
| NCT03786692 | Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC | ||
| NCT03007641 | Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient | ||
| NCT05880667 | Adaptive Radiation for Abdominopelvic Metastases | ||
| NCT03095209 | Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery | ||
| NCT03179943 | Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma | ||
| NCT02633540 | Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function | ||
| NCT06416150 | Reducing Urban Cervical Cancer Disparities | ||
| NCT00043108 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | ||
| NCT02968732 | Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder | ||
| NCT03179956 | Impact of Ribociclib on Head and Neck Squamous Cell Cancer | ||
| NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | ||
| NCT01316757 | Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer | ||
| NCT05427240 | eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer | ||
| NCT06050954 | A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA) | ||
| NCT04441749 | nCLE For Diagnosis Of Peripheral Lung Nodules By Robotic Navigational Bronchoscopy | ||
| NCT02594826 | Cervical Cancer Screening Intervention Among Korean American Women | ||
| NCT00005848 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT02535247 | Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma | ||
| NCT02032550 | Treatment Preference and Patient Centered Prostate Cancer Care | ||
| NCT01288534 | Hypofractionated Stereotactic Body Radiation Therapy (SBRT) | ||
| NCT04242667 | Penn Biobank Return of Research Results Program | ||
| NCT05498792 | Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma | ||
| NCT01031420 | Dose Dense MVAC for Muscle Invasive Bladder Cancer | ||
| NCT04506554 | A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer | ||
| NCT01332279 | Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy | ||
| NCT03291028 | Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma | ||
| NCT01471964 | Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer | ||
| NCT04733794 | Feasibility Bowel Dysfunction Program After Low Anterior Resection | ||
| NCT03177057 | SMART Project in Preventing Skin Cancer | ||
| NCT07663422 | Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy | ||
| NCT07221942 | Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma | ||
| NCT03930797 | Coping Together After Breast Cancer | ||
| NCT01840150 | Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer | ||
| NCT02088775 | PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer | ||
| NCT06222242 | mychoiceTM Implementation With Medical Oncology Patients | ||
| NCT00653146 | The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia | ||
| NCT00694291 | Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer | ||
| NCT02609230 | A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma | ||
| NCT01982591 | Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy | ||
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | ||
| NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | ||
| NCT03527108 | Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC | ||
| NCT05274048 | Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients | ||
| NCT04055753 | Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma | ||
| NCT02614456 | Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors | ||
| NCT07221058 | Adaptive Radiation Boost for Rectal Cancer | ||
| NCT06436846 | Genomic Risk in Retroperitoneal Sarcoma |
